Open Access
Open access
Pharmaceuticals, volume 14, issue 2, pages 96

The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure

Susie L. Brown 1
Samantha Kendrick 1
1
 
Biochemistry and Molecular Biology Department, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Publication typeJournal Article
Publication date2021-01-27
Journal: Pharmaceuticals
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor4.6
ISSN14248247, 14248247
PubMed ID:  33513764
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract

Stretches of cytosine-rich DNA are capable of adopting a dynamic secondary structure, the i-motif. When within promoter regions, the i-motif has the potential to act as a molecular switch for controlling gene expression. However, i-motif structures in genomic areas of repetitive nucleotide sequences may play a role in facilitating or hindering expansion of these DNA elements. Despite research on the i-motif trailing behind the complementary G-quadruplex structure, recent discoveries including the identification of a specific i-motif antibody are pushing this field forward. This perspective reviews initial and current work characterizing the i-motif and providing insight into the biological function of this DNA structure, with a focus on how the i-motif can serve as a molecular target for developing new therapeutic approaches to modulate gene expression and extension of repetitive DNA.

Top-30

Journals

1
2
3
4
5
International Journal of Molecular Sciences
5 publications, 9.09%
Nucleic Acids Research
5 publications, 9.09%
Chemical Communications
2 publications, 3.64%
International Journal of Biological Macromolecules
2 publications, 3.64%
Pharmaceuticals
1 publication, 1.82%
Frontiers in Genetics
1 publication, 1.82%
Frontiers in Molecular Biosciences
1 publication, 1.82%
Entropy
1 publication, 1.82%
Journal of Materials Research
1 publication, 1.82%
ACS Applied Nano Materials
1 publication, 1.82%
iScience
1 publication, 1.82%
Bioorganic and Medicinal Chemistry
1 publication, 1.82%
Biochimie
1 publication, 1.82%
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.82%
Journal of Inorganic Biochemistry
1 publication, 1.82%
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 publication, 1.82%
Photodiagnosis and Photodynamic Therapy
1 publication, 1.82%
Journal of Physical Chemistry A
1 publication, 1.82%
ACS Omega
1 publication, 1.82%
Journal of Physical Chemistry Letters
1 publication, 1.82%
Journal of Physical Chemistry B
1 publication, 1.82%
RSC Medicinal Chemistry
1 publication, 1.82%
Dalton Transactions
1 publication, 1.82%
RSC Chemical Biology
1 publication, 1.82%
NAR Cancer
1 publication, 1.82%
Biomedical Optics Express
1 publication, 1.82%
Journal of the American Society for Mass Spectrometry
1 publication, 1.82%
Photochemistry and Photobiology
1 publication, 1.82%
Biopolymers
1 publication, 1.82%
1
2
3
4
5

Publishers

2
4
6
8
10
12
Elsevier
12 publications, 21.82%
MDPI
8 publications, 14.55%
Royal Society of Chemistry (RSC)
7 publications, 12.73%
American Chemical Society (ACS)
7 publications, 12.73%
Oxford University Press
6 publications, 10.91%
Wiley
4 publications, 7.27%
Frontiers Media S.A.
2 publications, 3.64%
Cambridge University Press
1 publication, 1.82%
Optica Publishing Group
1 publication, 1.82%
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 1.82%
Cold Spring Harbor Laboratory
1 publication, 1.82%
Acta Naturae Ltd
1 publication, 1.82%
Taylor & Francis
1 publication, 1.82%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.82%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Brown S. L., Kendrick S. The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure // Pharmaceuticals. 2021. Vol. 14. No. 2. p. 96.
GOST all authors (up to 50) Copy
Brown S. L., Kendrick S. The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure // Pharmaceuticals. 2021. Vol. 14. No. 2. p. 96.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ph14020096
UR - https://doi.org/10.3390/ph14020096
TI - The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure
T2 - Pharmaceuticals
AU - Brown, Susie L.
AU - Kendrick, Samantha
PY - 2021
DA - 2021/01/27
PB - MDPI
SP - 96
IS - 2
VL - 14
PMID - 33513764
SN - 1424-8247
SN - 1424-8247
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Brown,
author = {Susie L. Brown and Samantha Kendrick},
title = {The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure},
journal = {Pharmaceuticals},
year = {2021},
volume = {14},
publisher = {MDPI},
month = {jan},
url = {https://doi.org/10.3390/ph14020096},
number = {2},
pages = {96},
doi = {10.3390/ph14020096}
}
MLA
Cite this
MLA Copy
Brown, Susie L., and Samantha Kendrick. “The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure.” Pharmaceuticals, vol. 14, no. 2, Jan. 2021, p. 96. https://doi.org/10.3390/ph14020096.
Found error?